A range of food and supplement products that claim to boost the immune system, prevent diabetes and ageing has come under the attention of the Japanese authorities.
Swiss firm Caviarlieri Limited is expanding further across Asia and Australia with its caviar-containing anti-ageing product, after seeing initial success in the Philippines and Thailand.
A trial involving healthy Japanese men has shown for the first time that a single dose of nicotinamide mononucleotide (NMN) is safe for consumption and is effectively metabolised by the body.
China’s nicotinamide mononucleotide (NMN) supplier EffePharm is embarking on its first human clinical trial as it seeks to validate the anti-ageing effects and safety of its ingredient “Uthever”.
This round up of finished-product brands looks at the plans that Chinese health foods giant BY-HEALTH has for its new research centre, Blackmores' ambitions in India, probiotic firm TargEDys' appetite-controlling product and more.